'Women's Viagra': FDA Panel Hears Testimony as Advocates Push for Pill

Women testified about their fears of never being able to have sex again at a Food and Drug Administration (FDA) hearing in Washington on Thursday, in an effort to push the agency to approve a drug that is touted as “women’s viagra”.
A coalition of women’s groups and the drug’s manufacturer are advocating for approval of the pill, Flibanserin. “I should be able to determine if Flibanserin is worth the benefit of treatment,” said Amanda Parrish, one of more than 11,000 women who participated in a clinical trial of the pill.



wochit_news